Adrenoleukodystrophy (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Adrenoleukodystrophy" in English language version.

refsWebsite

Global rank English rank

40nih.gov

4^th place

30doi.org

2^nd place

8worldcat.org

5^th place

8semanticscholar.org

11^th place

8^th place

7web.archive.org

1^st place

3elsevier.com

610^th place

704^th place

1wiley.com

222^nd place

297^th place

1omim.org

4,380^th place

4,305^th place

1neurology.org

9,919^th place

low place

1cambridge.org

305^th place

264^th place

1ajnr.org

low place

1uzh.ch

3,633^rd place

3,091^st place

1harvard.edu

18^th place

17^th place

1fiercepharma.com

low place

8,921^st place

1europa.eu

68^th place

117^th place

1businesswire.com

615^th place

407^th place

1sps.nhs.uk

low place

1science.org

1,160^th place

737^th place

1researchgate.net

120^th place

125^th place

ajnr.org (Global: low place; English: low place)

Loes, Daniel J.; Hite, S; Moser, H; Stillman, A E; Shapiro, E; Lockman, L; Latchaw, R E; Krivit, W (October 1994). "Adrenoleukodystrophy: a scoring method for brain MR observations". American Journal of Neuroradiology. 15 (9): 1761–1766. PMC 8333737. PMID 7847225. Archived from the original on September 1, 2015. Retrieved January 17, 2013.

businesswire.com (Global: 615^th place; English: 407^th place)

"Bluebird Bio Receives Positive CHMP Opinion for Skysona (elivaldogene autotemcel, Lenti-D) Gene Therapy for Patients Less Than 18 Years of Age with Early Cerebral Adrenoleukodystrophy (CALD)" (Press release). Bluebird Bio. 21 May 2021. Archived from the original on 2 June 2021. Retrieved 1 June 2021 – via Business Wire.

cambridge.org (Global: 305^th place; English: 264^th place)

Budhram, Adrian; Pandey, Sachin K. (September 2017). "Activation of Cerebral X-linked Adrenoleukodystrophy After Head Trauma". Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 44 (5): 597–598. doi:10.1017/cjn.2017.52. ISSN 0317-1671. PMID 28534457.

doi.org (Global: 2^nd place; English: 2^nd place)

Huffnagel, Irene C.; Dijkgraaf, Marcel G. W.; Janssens, Georges E.; van Weeghel, Michel; van Geel, Björn M.; Poll-The, Bwee Tien; Kemp, Stephan; Engelen, Marc (2019-02-07). "Disease progression in women with X-linked adrenoleukodystrophy is slow". Orphanet Journal of Rare Diseases. 14 (1): 30. doi:10.1186/s13023-019-1008-6. ISSN 1750-1172. PMC 6367840. PMID 30732635.
Berger, Johannes; Gärtner, Jutta (December 2006). "X-linked adrenoleukodystrophy: Clinical, biochemical and pathogenetic aspects". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1763 (12): 1721–1732. doi:10.1016/j.bbamcr.2006.07.010. PMID 16949688.
Bezman, Lena; Moser, Ann B.; Raymond, Gerald V.; Rinaldo, Piero; Watkins, Paul A.; Smith, Kirby D.; Kass, Nancy E.; Moser, Hugo W. (2001). "Adrenoleukodystrophy: Incidence, new mutation rate, and results of extended family screening". Annals of Neurology. 49 (4): 512–517. doi:10.1002/ana.101. ISSN 1531-8249. PMID 11310629.
Berger, Johannes; Gärtner, Jutta (December 2006). "X-linked adrenoleukodystrophy: Clinical, biochemical and pathogenetic aspects". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1763 (12): 1721–1732. doi:10.1016/j.bbamcr.2006.07.010. PMID 16949688.
Hung, Kun-Long; Wang, Jinn-Shyan; Keng, Wee Teik; Chen, Hui-Ju; Liang, Jao-Shwann; Ngu, Lock Hock; Lu, Jyh-Feng (September 2013). "Mutational Analyses on X-Linked Adrenoleukodystrophy Reveal a Novel Cryptic Splicing and Three Missense Mutations in the ABCD1 Gene". Pediatric Neurology. 49 (3): 185–190. doi:10.1016/j.pediatrneurol.2013.04.021. PMID 23835273.
Smith, Kirby D.; Kemp, Stephan; Braiterman, Lelita T.; Lu, Jyh-Feng; Wei, He-Ming; Geraghty, Michael; Stetten, Gail; Bergin, James S.; Pevsner, Jonathan; Watkins, Paul A. (1999). "X-linked adrenoleukodystrophy: Genes, mutations, and phenotypes". Neurochemical Research. 24 (4): 521–535. doi:10.1023/a:1022535930009. PMID 10227685. S2CID 38326524.
Cartier, Nathalie; Aubourg, Patrick (27 October 2009). "Hematopoietic Stem Cell Transplantation and Hematopoietic Stem Cell Gene Therapy in X-Linked Adrenoleukodystrophy". Brain Pathology. 20 (4): 857–862. doi:10.1111/j.1750-3639.2010.00394.x. PMC 8094635. PMID 20626747. S2CID 24182017.
Raymond, Gerald V.; Seidman, Roberta; Monteith, Teshamae S.; Kolodny, Edwin; Sathe, Swati; Mahmood, Asif; Powers, James M. (March 2010). "Head trauma can initiate the onset of adreno-leukodystrophy". Journal of the Neurological Sciences. 290 (1–2): 70–74. doi:10.1016/j.jns.2009.11.005. PMID 19945717.
Bouquet, Floriane; Dehais, Caroline; Sanson, Marc; Lubetzki, Catherine; Louapre, Céline (December 2015). "Dramatic worsening of adult-onset X-linked adrenoleukodystrophy after head trauma". Neurology. 85 (22): 1991–1993. doi:10.1212/WNL.0000000000002173. ISSN 0028-3878. PMID 26537054.
Budhram, Adrian; Pandey, Sachin K. (September 2017). "Activation of Cerebral X-linked Adrenoleukodystrophy After Head Trauma". Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 44 (5): 597–598. doi:10.1017/cjn.2017.52. ISSN 0317-1671. PMID 28534457.
Wang, Qiu-Hong; Wang, Jing; Wang, Yang-Yang; He, Wen; Feng, Chen; Gao, Jing; Lu, Qian; Wang, Yi; Dun, Shuo; Zhang, Qi; Zou, Li-Ping (March 2024). "Accelerated Course of Cerebral Adrenoleukodystrophy After Coronavirus Disease 2019 Infection". Pediatric Neurology. 152: 87–92. doi:10.1016/j.pediatrneurol.2023.12.021. PMID 38237318.
Moser, Ann B.; Kreiter, Nancy; Bezman, Lena; Lu, Shou-En; Raymond, Gerald V.; Naidu, Sakkubai; Moser, Hugo W. (January 1999). "Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls". Annals of Neurology. 45 (1): 100–110. doi:10.1002/1531-8249(199901)45:1<100::aid-art16>3.0.co;2-u. PMID 9894883. S2CID 24516921.
Sandlers, Yana; Moser, Ann B.; Hubbard, Walter C.; Kratz, Lisa E.; Jones, Richard O.; Raymond, Gerald V. (March 2012). "Combined extraction of acyl carnitines and 26:0 lysophosphatidylcholine from dried blood spots: Prospective newborn screening for X-linked adrenoleukodystrophy". Molecular Genetics and Metabolism. 105 (3): 416–420. doi:10.1016/j.ymgme.2011.11.195. PMID 22197596.
Hubbard, Walter C.; Moser, Ann B.; Liu, Anita C.; Jones, Richard O.; Steinberg, Steven J.; Lorey, Fred; Panny, Susan R.; Vogt Jr., Robert F.; Macaya, Daniela; Turgeon, Coleman T.; Tortorelli, S; Raymond, GV (July 2009). "Newborn screening for X-linked adrenoleukodystrophy (X-ALD): Validation of a combined liquid chromatography–tandem mass spectrometric (LC–MS/MS) method". Molecular Genetics and Metabolism. 97 (3): 212–220. doi:10.1016/j.ymgme.2009.03.010. PMID 19423374.
Raymond, Gerald V.; Jones, Richard O.; Moser, Ann B. (16 August 2012). "Newborn Screening for Adrenoleukodystrophy". Molecular Diagnosis & Therapy. 11 (6): 381–384. doi:10.1007/BF03256261. PMID 18078355. S2CID 21323198.
Moser, Hugo W.; Moser, Ann B.; Hollandsworth, Kim; Brereton, N. Hong; Raymond, Gerald V. (24 August 2007). "'Lorenzo's Oil' Therapy for X-linked Adrenoleukodystrophy: Rationale and Current Assessment of Efficacy". Journal of Molecular Neuroscience. 33 (1): 105–113. doi:10.1007/s12031-007-0041-4. PMID 17901554. S2CID 21333247.
Semmler, Alexander; Köhler, Wolfgang; Jung, Hans H; Weller, Michael; Linnebank, Michael (9 January 2014). "Therapy of X-linked adrenoleukodystrophy" (PDF). Expert Review of Neurotherapeutics. 8 (9): 1367–1379. doi:10.1586/14737175.8.9.1367. PMID 18759549. S2CID 207195153. Archived (PDF) from the original on 13 April 2021. Retrieved 4 January 2020.
Cappa, M.; Bizzarri, C.; Petroni, A.; Carta, G.; Cordeddu, L.; Valeriani, M.; Vollono, C.; De Pasquale, L.; Blasevich, M.; Banni, S. (2012). "A mixture of oleic, erucic and conjugated linoleic acids modulates cerebrospinal fluid inflammatory markers and improve somatosensorial evoked potential in X-linked adrenoleukodystrophy female carriers". Journal of Inherited Metabolic Disease. 35 (5): 899–907. doi:10.1007/s10545-011-9432-3. PMC 3432215. PMID 22189598.
López-Erauskin, J.; Fourcade, S.; Galino, J.; Ruiz, M.; Schlüter, A.; Naudi, A.; Jove, M.; Portero-Otin, M.; Pamplona, R.; Ferrer, I.; Pujol, A. (2011). "Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy". Annals of Neurology. 70 (1): 84–92. doi:10.1002/ana.22363. PMC 3229843. PMID 21786300.
Diczfalusy, U.; Alexson, S. E. (1990). "Identification of metabolites from peroxisomal beta-oxidation of prostaglandins". Journal of Lipid Research. 31 (2): 307–314. doi:10.1016/S0022-2275(20)43216-X. PMID 2324649.
De Waart, D. R.; Koomen, G. C.; Wanders, R. J. (1994). "Studies on the urinary excretion of thromboxane B2 in Zellweger patients and control subjects: evidence for a major role for peroxisomes in the beta-oxidative chain-shortening of thromboxane B2". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1226 (1): 44–48. doi:10.1016/0925-4439(94)90057-4. PMID 8155738.
Ferdinandusse, S.; Meissner, T.; Wanders, R. J.; Mayatepek, E. (2002). "Identification of the peroxisomal beta-oxidation enzymes involved in the degradation of leukotrienes". Biochemical and Biophysical Research Communications. 293 (1): 269–273. Bibcode:2002BBRC..293..269F. doi:10.1016/S0006-291X(02)00214-0. PMID 12054595.
Mayatepek, E.; Lehmann, W. D. (1996). "12- and 15-hydroxyeicosatetraenoic acid are excreted in the urine of peroxisome-deficient patients: evidence for peroxisomal metabolism in vivo". Pediatric Research. 39 (1): 146–149. doi:10.1203/00006450-199601000-00022. PMID 8825400. S2CID 20240456.
Iannone, A.; Petroni, A.; Murru, E.; Cordeddu, L.; Carta, G.; Melis, M. P.; Bergamini, S.; Casa, L. D.; Cappiello, L.; Carissimi, R.; O'Shea, M.; Bell, D.; De Santis, E.; Banni, S. (2009). "Impairment of 8-iso-PGF(2ALPHA) isoprostane metabolism by dietary conjugated linoleic acid (CLA)". Prostaglandins, Leukotrienes, and Essential Fatty Acids. 80 (5–6): 279–287. doi:10.1016/j.plefa.2009.02.008. PMID 19403295.
Restuccia, D.; Di Lazzaro, V.; Valeriani, M.; Oliviero, A.; Le Pera, D.; Colosimo, C.; Burdi, N.; Cappa, M.; Bertini, E.; Di Biase, A.; Tonali, P. (1997). "Neurophysiological abnormalities in adrenoleukodystrophy carriers. Evidence of different degrees of central nervous system involvement". Brain. 120 (7): 1139–1148. doi:10.1093/brain/120.7.1139. PMID 9236627.
Petryk, A; Polgreen, L E; Chahla, S; Miller, W; Orchard, P J (5 March 2012). "No evidence for the reversal of adrenal failure after hematopoietic cell transplantation in X-linked adrenoleukodystrophy". Bone Marrow Transplantation. 47 (10): 1377–1378. doi:10.1038/bmt.2012.33. PMC 4547590. PMID 22388279.
Morató, Laia; Galino, Jorge; Ruiz, Montserrat; Calingasan, Noel Ylagan; Starkov, Anatoly A.; Dumont, Magali; Naudí, Alba; Martínez, Juan José; Aubourg, Patrick; Portero-Otín, Manuel; Pamplona, Reinald; Galea, Elena; Beal, M. Flint; Ferrer, Isidre; Fourcade, Stéphane (August 2013). "Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy". Brain. 136 (8): 2432–2443. doi:10.1093/brain/awt143. ISSN 1460-2156. PMC 4550111. PMID 23794606.
Rodríguez-Pascau, Laura; Vilalta, Anna; Cerrada, Marc; Traver, Estefania; Forss-Petter, Sonja; Weinhofer, Isabelle; Bauer, Jan; Kemp, Stephan; Pina, Guillem; Pascual, Sílvia; Meya, Uwe; Musolino, Patricia L.; Berger, Johannes; Martinell, Marc; Pizcueta, Pilar (2021-06-02). "The brain penetrant PPARγ agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy". Science Translational Medicine. 13 (596) eabc0555. doi:10.1126/scitranslmed.abc0555. ISSN 1946-6234. PMID 34078742.
Köhler, Wolfgang; Engelen, Marc; Eichler, Florian; Lachmann, Robin; Fatemi, Ali; Sampson, Jacinda; Salsano, Ettore; Gamez, Josep; Molnar, Maria Judit; Pascual, Sílvia; Rovira, Maria; Vilà, Anna; Pina, Guillem; Martín-Ugarte, Itziar; Mantilla, Adriana (2023-02-01). "Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2–3 trial". The Lancet Neurology. 22 (2): 127–136. doi:10.1016/S1474-4422(22)00495-1. ISSN 1474-4422. PMC 11847323. PMID 36681445.
Poll-The, Bwee; Engelen, Marc (15 March 2012). "Peroxisomal Leukoencephalopathy". Seminars in Neurology. 32 (1): 042–050. doi:10.1055/s-0032-1306385. PMID 22422205. S2CID 39152217.

elsevier.com (Global: 610^th place; English: 704^th place)

linkinghub.elsevier.com

Berger, Johannes; Gärtner, Jutta (December 2006). "X-linked adrenoleukodystrophy: Clinical, biochemical and pathogenetic aspects". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1763 (12): 1721–1732. doi:10.1016/j.bbamcr.2006.07.010. PMID 16949688.
Raymond, Gerald V.; Seidman, Roberta; Monteith, Teshamae S.; Kolodny, Edwin; Sathe, Swati; Mahmood, Asif; Powers, James M. (March 2010). "Head trauma can initiate the onset of adreno-leukodystrophy". Journal of the Neurological Sciences. 290 (1–2): 70–74. doi:10.1016/j.jns.2009.11.005. PMID 19945717.
Wang, Qiu-Hong; Wang, Jing; Wang, Yang-Yang; He, Wen; Feng, Chen; Gao, Jing; Lu, Qian; Wang, Yi; Dun, Shuo; Zhang, Qi; Zou, Li-Ping (March 2024). "Accelerated Course of Cerebral Adrenoleukodystrophy After Coronavirus Disease 2019 Infection". Pediatric Neurology. 152: 87–92. doi:10.1016/j.pediatrneurol.2023.12.021. PMID 38237318.

europa.eu (Global: 68^th place; English: 117^th place)

ema.europa.eu

"Skysona: Pending EC decision". European Medicines Agency (EMA). 21 May 2021. Archived from the original on 2 June 2021. Retrieved 1 June 2021.

fiercepharma.com (Global: low place; English: 8,921^st place)

Liu, Angus (September 19, 2022). "A $3M gene therapy: Bluebird bio breaks its own pricing record with FDA approval of Skysona". Fierce Pharma. Retrieved November 1, 2023.

harvard.edu (Global: 18^th place; English: 17^th place)

ui.adsabs.harvard.edu

Ferdinandusse, S.; Meissner, T.; Wanders, R. J.; Mayatepek, E. (2002). "Identification of the peroxisomal beta-oxidation enzymes involved in the degradation of leukotrienes". Biochemical and Biophysical Research Communications. 293 (1): 269–273. Bibcode:2002BBRC..293..269F. doi:10.1016/S0006-291X(02)00214-0. PMID 12054595.

neurology.org (Global: 9,919^th place; English: low place)

Bouquet, Floriane; Dehais, Caroline; Sanson, Marc; Lubetzki, Catherine; Louapre, Céline (December 2015). "Dramatic worsening of adult-onset X-linked adrenoleukodystrophy after head trauma". Neurology. 85 (22): 1991–1993. doi:10.1212/WNL.0000000000002173. ISSN 0028-3878. PMID 26537054.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Huffnagel, Irene C.; Dijkgraaf, Marcel G. W.; Janssens, Georges E.; van Weeghel, Michel; van Geel, Björn M.; Poll-The, Bwee Tien; Kemp, Stephan; Engelen, Marc (2019-02-07). "Disease progression in women with X-linked adrenoleukodystrophy is slow". Orphanet Journal of Rare Diseases. 14 (1): 30. doi:10.1186/s13023-019-1008-6. ISSN 1750-1172. PMC 6367840. PMID 30732635.
Berger, Johannes; Gärtner, Jutta (December 2006). "X-linked adrenoleukodystrophy: Clinical, biochemical and pathogenetic aspects". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1763 (12): 1721–1732. doi:10.1016/j.bbamcr.2006.07.010. PMID 16949688.
Bezman, Lena; Moser, Ann B.; Raymond, Gerald V.; Rinaldo, Piero; Watkins, Paul A.; Smith, Kirby D.; Kass, Nancy E.; Moser, Hugo W. (2001). "Adrenoleukodystrophy: Incidence, new mutation rate, and results of extended family screening". Annals of Neurology. 49 (4): 512–517. doi:10.1002/ana.101. ISSN 1531-8249. PMID 11310629.
Berger, Johannes; Gärtner, Jutta (December 2006). "X-linked adrenoleukodystrophy: Clinical, biochemical and pathogenetic aspects". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1763 (12): 1721–1732. doi:10.1016/j.bbamcr.2006.07.010. PMID 16949688.
Raymond GV, Moser AB, Fatemi A (6 April 2023) [Originally published 26 March 1999]. "X-Linked Adrenoleukodystrophy". In Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Stephens K, Amemiya A (eds.). GeneReviews. Seattle: University of Washington, Seattle. ISSN 2372-0697. PMID 20301491. National Library of Medicine Bookshelf ID NBK1315.
Hung, Kun-Long; Wang, Jinn-Shyan; Keng, Wee Teik; Chen, Hui-Ju; Liang, Jao-Shwann; Ngu, Lock Hock; Lu, Jyh-Feng (September 2013). "Mutational Analyses on X-Linked Adrenoleukodystrophy Reveal a Novel Cryptic Splicing and Three Missense Mutations in the ABCD1 Gene". Pediatric Neurology. 49 (3): 185–190. doi:10.1016/j.pediatrneurol.2013.04.021. PMID 23835273.
Smith, Kirby D.; Kemp, Stephan; Braiterman, Lelita T.; Lu, Jyh-Feng; Wei, He-Ming; Geraghty, Michael; Stetten, Gail; Bergin, James S.; Pevsner, Jonathan; Watkins, Paul A. (1999). "X-linked adrenoleukodystrophy: Genes, mutations, and phenotypes". Neurochemical Research. 24 (4): 521–535. doi:10.1023/a:1022535930009. PMID 10227685. S2CID 38326524.
Cartier, Nathalie; Aubourg, Patrick (27 October 2009). "Hematopoietic Stem Cell Transplantation and Hematopoietic Stem Cell Gene Therapy in X-Linked Adrenoleukodystrophy". Brain Pathology. 20 (4): 857–862. doi:10.1111/j.1750-3639.2010.00394.x. PMC 8094635. PMID 20626747. S2CID 24182017.
Raymond, Gerald V.; Seidman, Roberta; Monteith, Teshamae S.; Kolodny, Edwin; Sathe, Swati; Mahmood, Asif; Powers, James M. (March 2010). "Head trauma can initiate the onset of adreno-leukodystrophy". Journal of the Neurological Sciences. 290 (1–2): 70–74. doi:10.1016/j.jns.2009.11.005. PMID 19945717.
Bouquet, Floriane; Dehais, Caroline; Sanson, Marc; Lubetzki, Catherine; Louapre, Céline (December 2015). "Dramatic worsening of adult-onset X-linked adrenoleukodystrophy after head trauma". Neurology. 85 (22): 1991–1993. doi:10.1212/WNL.0000000000002173. ISSN 0028-3878. PMID 26537054.
Budhram, Adrian; Pandey, Sachin K. (September 2017). "Activation of Cerebral X-linked Adrenoleukodystrophy After Head Trauma". Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 44 (5): 597–598. doi:10.1017/cjn.2017.52. ISSN 0317-1671. PMID 28534457.
Wang, Qiu-Hong; Wang, Jing; Wang, Yang-Yang; He, Wen; Feng, Chen; Gao, Jing; Lu, Qian; Wang, Yi; Dun, Shuo; Zhang, Qi; Zou, Li-Ping (March 2024). "Accelerated Course of Cerebral Adrenoleukodystrophy After Coronavirus Disease 2019 Infection". Pediatric Neurology. 152: 87–92. doi:10.1016/j.pediatrneurol.2023.12.021. PMID 38237318.
Moser, Ann B.; Kreiter, Nancy; Bezman, Lena; Lu, Shou-En; Raymond, Gerald V.; Naidu, Sakkubai; Moser, Hugo W. (January 1999). "Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls". Annals of Neurology. 45 (1): 100–110. doi:10.1002/1531-8249(199901)45:1<100::aid-art16>3.0.co;2-u. PMID 9894883. S2CID 24516921.
Sandlers, Yana; Moser, Ann B.; Hubbard, Walter C.; Kratz, Lisa E.; Jones, Richard O.; Raymond, Gerald V. (March 2012). "Combined extraction of acyl carnitines and 26:0 lysophosphatidylcholine from dried blood spots: Prospective newborn screening for X-linked adrenoleukodystrophy". Molecular Genetics and Metabolism. 105 (3): 416–420. doi:10.1016/j.ymgme.2011.11.195. PMID 22197596.
Hubbard, Walter C.; Moser, Ann B.; Liu, Anita C.; Jones, Richard O.; Steinberg, Steven J.; Lorey, Fred; Panny, Susan R.; Vogt Jr., Robert F.; Macaya, Daniela; Turgeon, Coleman T.; Tortorelli, S; Raymond, GV (July 2009). "Newborn screening for X-linked adrenoleukodystrophy (X-ALD): Validation of a combined liquid chromatography–tandem mass spectrometric (LC–MS/MS) method". Molecular Genetics and Metabolism. 97 (3): 212–220. doi:10.1016/j.ymgme.2009.03.010. PMID 19423374.
Raymond, Gerald V.; Jones, Richard O.; Moser, Ann B. (16 August 2012). "Newborn Screening for Adrenoleukodystrophy". Molecular Diagnosis & Therapy. 11 (6): 381–384. doi:10.1007/BF03256261. PMID 18078355. S2CID 21323198.
Loes, Daniel J.; Hite, S; Moser, H; Stillman, A E; Shapiro, E; Lockman, L; Latchaw, R E; Krivit, W (October 1994). "Adrenoleukodystrophy: a scoring method for brain MR observations". American Journal of Neuroradiology. 15 (9): 1761–1766. PMC 8333737. PMID 7847225. Archived from the original on September 1, 2015. Retrieved January 17, 2013.
Moser, Hugo W.; Moser, Ann B.; Hollandsworth, Kim; Brereton, N. Hong; Raymond, Gerald V. (24 August 2007). "'Lorenzo's Oil' Therapy for X-linked Adrenoleukodystrophy: Rationale and Current Assessment of Efficacy". Journal of Molecular Neuroscience. 33 (1): 105–113. doi:10.1007/s12031-007-0041-4. PMID 17901554. S2CID 21333247.
Semmler, Alexander; Köhler, Wolfgang; Jung, Hans H; Weller, Michael; Linnebank, Michael (9 January 2014). "Therapy of X-linked adrenoleukodystrophy" (PDF). Expert Review of Neurotherapeutics. 8 (9): 1367–1379. doi:10.1586/14737175.8.9.1367. PMID 18759549. S2CID 207195153. Archived (PDF) from the original on 13 April 2021. Retrieved 4 January 2020.
Cappa, M.; Bizzarri, C.; Petroni, A.; Carta, G.; Cordeddu, L.; Valeriani, M.; Vollono, C.; De Pasquale, L.; Blasevich, M.; Banni, S. (2012). "A mixture of oleic, erucic and conjugated linoleic acids modulates cerebrospinal fluid inflammatory markers and improve somatosensorial evoked potential in X-linked adrenoleukodystrophy female carriers". Journal of Inherited Metabolic Disease. 35 (5): 899–907. doi:10.1007/s10545-011-9432-3. PMC 3432215. PMID 22189598.
López-Erauskin, J.; Fourcade, S.; Galino, J.; Ruiz, M.; Schlüter, A.; Naudi, A.; Jove, M.; Portero-Otin, M.; Pamplona, R.; Ferrer, I.; Pujol, A. (2011). "Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy". Annals of Neurology. 70 (1): 84–92. doi:10.1002/ana.22363. PMC 3229843. PMID 21786300.
Diczfalusy, U.; Alexson, S. E. (1990). "Identification of metabolites from peroxisomal beta-oxidation of prostaglandins". Journal of Lipid Research. 31 (2): 307–314. doi:10.1016/S0022-2275(20)43216-X. PMID 2324649.
De Waart, D. R.; Koomen, G. C.; Wanders, R. J. (1994). "Studies on the urinary excretion of thromboxane B2 in Zellweger patients and control subjects: evidence for a major role for peroxisomes in the beta-oxidative chain-shortening of thromboxane B2". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1226 (1): 44–48. doi:10.1016/0925-4439(94)90057-4. PMID 8155738.
Ferdinandusse, S.; Meissner, T.; Wanders, R. J.; Mayatepek, E. (2002). "Identification of the peroxisomal beta-oxidation enzymes involved in the degradation of leukotrienes". Biochemical and Biophysical Research Communications. 293 (1): 269–273. Bibcode:2002BBRC..293..269F. doi:10.1016/S0006-291X(02)00214-0. PMID 12054595.
Mayatepek, E.; Lehmann, W. D. (1996). "12- and 15-hydroxyeicosatetraenoic acid are excreted in the urine of peroxisome-deficient patients: evidence for peroxisomal metabolism in vivo". Pediatric Research. 39 (1): 146–149. doi:10.1203/00006450-199601000-00022. PMID 8825400. S2CID 20240456.
Iannone, A.; Petroni, A.; Murru, E.; Cordeddu, L.; Carta, G.; Melis, M. P.; Bergamini, S.; Casa, L. D.; Cappiello, L.; Carissimi, R.; O'Shea, M.; Bell, D.; De Santis, E.; Banni, S. (2009). "Impairment of 8-iso-PGF(2ALPHA) isoprostane metabolism by dietary conjugated linoleic acid (CLA)". Prostaglandins, Leukotrienes, and Essential Fatty Acids. 80 (5–6): 279–287. doi:10.1016/j.plefa.2009.02.008. PMID 19403295.
Restuccia, D.; Di Lazzaro, V.; Valeriani, M.; Oliviero, A.; Le Pera, D.; Colosimo, C.; Burdi, N.; Cappa, M.; Bertini, E.; Di Biase, A.; Tonali, P. (1997). "Neurophysiological abnormalities in adrenoleukodystrophy carriers. Evidence of different degrees of central nervous system involvement". Brain. 120 (7): 1139–1148. doi:10.1093/brain/120.7.1139. PMID 9236627.
Petryk, A; Polgreen, L E; Chahla, S; Miller, W; Orchard, P J (5 March 2012). "No evidence for the reversal of adrenal failure after hematopoietic cell transplantation in X-linked adrenoleukodystrophy". Bone Marrow Transplantation. 47 (10): 1377–1378. doi:10.1038/bmt.2012.33. PMC 4547590. PMID 22388279.
Morató, Laia; Galino, Jorge; Ruiz, Montserrat; Calingasan, Noel Ylagan; Starkov, Anatoly A.; Dumont, Magali; Naudí, Alba; Martínez, Juan José; Aubourg, Patrick; Portero-Otín, Manuel; Pamplona, Reinald; Galea, Elena; Beal, M. Flint; Ferrer, Isidre; Fourcade, Stéphane (August 2013). "Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy". Brain. 136 (8): 2432–2443. doi:10.1093/brain/awt143. ISSN 1460-2156. PMC 4550111. PMID 23794606.
Rodríguez-Pascau, Laura; Vilalta, Anna; Cerrada, Marc; Traver, Estefania; Forss-Petter, Sonja; Weinhofer, Isabelle; Bauer, Jan; Kemp, Stephan; Pina, Guillem; Pascual, Sílvia; Meya, Uwe; Musolino, Patricia L.; Berger, Johannes; Martinell, Marc; Pizcueta, Pilar (2021-06-02). "The brain penetrant PPARγ agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy". Science Translational Medicine. 13 (596) eabc0555. doi:10.1126/scitranslmed.abc0555. ISSN 1946-6234. PMID 34078742.
Köhler, Wolfgang; Engelen, Marc; Eichler, Florian; Lachmann, Robin; Fatemi, Ali; Sampson, Jacinda; Salsano, Ettore; Gamez, Josep; Molnar, Maria Judit; Pascual, Sílvia; Rovira, Maria; Vilà, Anna; Pina, Guillem; Martín-Ugarte, Itziar; Mantilla, Adriana (2023-02-01). "Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2–3 trial". The Lancet Neurology. 22 (2): 127–136. doi:10.1016/S1474-4422(22)00495-1. ISSN 1474-4422. PMC 11847323. PMID 36681445.
Poll-The, Bwee; Engelen, Marc (15 March 2012). "Peroxisomal Leukoencephalopathy". Seminars in Neurology. 32 (1): 042–050. doi:10.1055/s-0032-1306385. PMID 22422205. S2CID 39152217.

ncbi.nlm.nih.gov

Huffnagel, Irene C.; Dijkgraaf, Marcel G. W.; Janssens, Georges E.; van Weeghel, Michel; van Geel, Björn M.; Poll-The, Bwee Tien; Kemp, Stephan; Engelen, Marc (2019-02-07). "Disease progression in women with X-linked adrenoleukodystrophy is slow". Orphanet Journal of Rare Diseases. 14 (1): 30. doi:10.1186/s13023-019-1008-6. ISSN 1750-1172. PMC 6367840. PMID 30732635.
Cartier, Nathalie; Aubourg, Patrick (27 October 2009). "Hematopoietic Stem Cell Transplantation and Hematopoietic Stem Cell Gene Therapy in X-Linked Adrenoleukodystrophy". Brain Pathology. 20 (4): 857–862. doi:10.1111/j.1750-3639.2010.00394.x. PMC 8094635. PMID 20626747. S2CID 24182017.
Loes, Daniel J.; Hite, S; Moser, H; Stillman, A E; Shapiro, E; Lockman, L; Latchaw, R E; Krivit, W (October 1994). "Adrenoleukodystrophy: a scoring method for brain MR observations". American Journal of Neuroradiology. 15 (9): 1761–1766. PMC 8333737. PMID 7847225. Archived from the original on September 1, 2015. Retrieved January 17, 2013.
Cappa, M.; Bizzarri, C.; Petroni, A.; Carta, G.; Cordeddu, L.; Valeriani, M.; Vollono, C.; De Pasquale, L.; Blasevich, M.; Banni, S. (2012). "A mixture of oleic, erucic and conjugated linoleic acids modulates cerebrospinal fluid inflammatory markers and improve somatosensorial evoked potential in X-linked adrenoleukodystrophy female carriers". Journal of Inherited Metabolic Disease. 35 (5): 899–907. doi:10.1007/s10545-011-9432-3. PMC 3432215. PMID 22189598.
López-Erauskin, J.; Fourcade, S.; Galino, J.; Ruiz, M.; Schlüter, A.; Naudi, A.; Jove, M.; Portero-Otin, M.; Pamplona, R.; Ferrer, I.; Pujol, A. (2011). "Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy". Annals of Neurology. 70 (1): 84–92. doi:10.1002/ana.22363. PMC 3229843. PMID 21786300.
Petryk, A; Polgreen, L E; Chahla, S; Miller, W; Orchard, P J (5 March 2012). "No evidence for the reversal of adrenal failure after hematopoietic cell transplantation in X-linked adrenoleukodystrophy". Bone Marrow Transplantation. 47 (10): 1377–1378. doi:10.1038/bmt.2012.33. PMC 4547590. PMID 22388279.
Morató, Laia; Galino, Jorge; Ruiz, Montserrat; Calingasan, Noel Ylagan; Starkov, Anatoly A.; Dumont, Magali; Naudí, Alba; Martínez, Juan José; Aubourg, Patrick; Portero-Otín, Manuel; Pamplona, Reinald; Galea, Elena; Beal, M. Flint; Ferrer, Isidre; Fourcade, Stéphane (August 2013). "Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy". Brain. 136 (8): 2432–2443. doi:10.1093/brain/awt143. ISSN 1460-2156. PMC 4550111. PMID 23794606.
Köhler, Wolfgang; Engelen, Marc; Eichler, Florian; Lachmann, Robin; Fatemi, Ali; Sampson, Jacinda; Salsano, Ettore; Gamez, Josep; Molnar, Maria Judit; Pascual, Sílvia; Rovira, Maria; Vilà, Anna; Pina, Guillem; Martín-Ugarte, Itziar; Mantilla, Adriana (2023-02-01). "Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2–3 trial". The Lancet Neurology. 22 (2): 127–136. doi:10.1016/S1474-4422(22)00495-1. ISSN 1474-4422. PMC 11847323. PMID 36681445.

omim.org (Global: 4,380^th place; English: 4,305^th place)

"#300100 - Adrenoleukodystrophy". Johns Hopkins University. Archived from the original on 2015-09-24. Retrieved 2012-06-27.

researchgate.net (Global: 120^th place; English: 125^th place)

"Asymptomatic adrenoleukodystrophy in elderly males | Request PDF". Archived from the original on 2021-04-18. Retrieved 2021-02-05.

science.org (Global: 1,160^th place; English: 737^th place)

Rodríguez-Pascau, Laura; Vilalta, Anna; Cerrada, Marc; Traver, Estefania; Forss-Petter, Sonja; Weinhofer, Isabelle; Bauer, Jan; Kemp, Stephan; Pina, Guillem; Pascual, Sílvia; Meya, Uwe; Musolino, Patricia L.; Berger, Johannes; Martinell, Marc; Pizcueta, Pilar (2021-06-02). "The brain penetrant PPARγ agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy". Science Translational Medicine. 13 (596) eabc0555. doi:10.1126/scitranslmed.abc0555. ISSN 1946-6234. PMID 34078742.

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

Smith, Kirby D.; Kemp, Stephan; Braiterman, Lelita T.; Lu, Jyh-Feng; Wei, He-Ming; Geraghty, Michael; Stetten, Gail; Bergin, James S.; Pevsner, Jonathan; Watkins, Paul A. (1999). "X-linked adrenoleukodystrophy: Genes, mutations, and phenotypes". Neurochemical Research. 24 (4): 521–535. doi:10.1023/a:1022535930009. PMID 10227685. S2CID 38326524.
Cartier, Nathalie; Aubourg, Patrick (27 October 2009). "Hematopoietic Stem Cell Transplantation and Hematopoietic Stem Cell Gene Therapy in X-Linked Adrenoleukodystrophy". Brain Pathology. 20 (4): 857–862. doi:10.1111/j.1750-3639.2010.00394.x. PMC 8094635. PMID 20626747. S2CID 24182017.
Moser, Ann B.; Kreiter, Nancy; Bezman, Lena; Lu, Shou-En; Raymond, Gerald V.; Naidu, Sakkubai; Moser, Hugo W. (January 1999). "Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls". Annals of Neurology. 45 (1): 100–110. doi:10.1002/1531-8249(199901)45:1<100::aid-art16>3.0.co;2-u. PMID 9894883. S2CID 24516921.
Raymond, Gerald V.; Jones, Richard O.; Moser, Ann B. (16 August 2012). "Newborn Screening for Adrenoleukodystrophy". Molecular Diagnosis & Therapy. 11 (6): 381–384. doi:10.1007/BF03256261. PMID 18078355. S2CID 21323198.
Moser, Hugo W.; Moser, Ann B.; Hollandsworth, Kim; Brereton, N. Hong; Raymond, Gerald V. (24 August 2007). "'Lorenzo's Oil' Therapy for X-linked Adrenoleukodystrophy: Rationale and Current Assessment of Efficacy". Journal of Molecular Neuroscience. 33 (1): 105–113. doi:10.1007/s12031-007-0041-4. PMID 17901554. S2CID 21333247.
Semmler, Alexander; Köhler, Wolfgang; Jung, Hans H; Weller, Michael; Linnebank, Michael (9 January 2014). "Therapy of X-linked adrenoleukodystrophy" (PDF). Expert Review of Neurotherapeutics. 8 (9): 1367–1379. doi:10.1586/14737175.8.9.1367. PMID 18759549. S2CID 207195153. Archived (PDF) from the original on 13 April 2021. Retrieved 4 January 2020.
Mayatepek, E.; Lehmann, W. D. (1996). "12- and 15-hydroxyeicosatetraenoic acid are excreted in the urine of peroxisome-deficient patients: evidence for peroxisomal metabolism in vivo". Pediatric Research. 39 (1): 146–149. doi:10.1203/00006450-199601000-00022. PMID 8825400. S2CID 20240456.
Poll-The, Bwee; Engelen, Marc (15 March 2012). "Peroxisomal Leukoencephalopathy". Seminars in Neurology. 32 (1): 042–050. doi:10.1055/s-0032-1306385. PMID 22422205. S2CID 39152217.

sps.nhs.uk (Global: low place; English: low place)

"Elivaldogene autotemcel". SPS - Specialist Pharmacy Service. 28 May 2021. Archived from the original on 2 June 2021. Retrieved 1 June 2021.

uzh.ch (Global: 3,633^rd place; English: 3,091^st place)

zora.uzh.ch

Semmler, Alexander; Köhler, Wolfgang; Jung, Hans H; Weller, Michael; Linnebank, Michael (9 January 2014). "Therapy of X-linked adrenoleukodystrophy" (PDF). Expert Review of Neurotherapeutics. 8 (9): 1367–1379. doi:10.1586/14737175.8.9.1367. PMID 18759549. S2CID 207195153. Archived (PDF) from the original on 13 April 2021. Retrieved 4 January 2020.

web.archive.org (Global: 1^st place; English: 1^st place)

"#300100 - Adrenoleukodystrophy". Johns Hopkins University. Archived from the original on 2015-09-24. Retrieved 2012-06-27.
Loes, Daniel J.; Hite, S; Moser, H; Stillman, A E; Shapiro, E; Lockman, L; Latchaw, R E; Krivit, W (October 1994). "Adrenoleukodystrophy: a scoring method for brain MR observations". American Journal of Neuroradiology. 15 (9): 1761–1766. PMC 8333737. PMID 7847225. Archived from the original on September 1, 2015. Retrieved January 17, 2013.
Semmler, Alexander; Köhler, Wolfgang; Jung, Hans H; Weller, Michael; Linnebank, Michael (9 January 2014). "Therapy of X-linked adrenoleukodystrophy" (PDF). Expert Review of Neurotherapeutics. 8 (9): 1367–1379. doi:10.1586/14737175.8.9.1367. PMID 18759549. S2CID 207195153. Archived (PDF) from the original on 13 April 2021. Retrieved 4 January 2020.
"Skysona: Pending EC decision". European Medicines Agency (EMA). 21 May 2021. Archived from the original on 2 June 2021. Retrieved 1 June 2021.
"Bluebird Bio Receives Positive CHMP Opinion for Skysona (elivaldogene autotemcel, Lenti-D) Gene Therapy for Patients Less Than 18 Years of Age with Early Cerebral Adrenoleukodystrophy (CALD)" (Press release). Bluebird Bio. 21 May 2021. Archived from the original on 2 June 2021. Retrieved 1 June 2021 – via Business Wire.
"Elivaldogene autotemcel". SPS - Specialist Pharmacy Service. 28 May 2021. Archived from the original on 2 June 2021. Retrieved 1 June 2021.
"Asymptomatic adrenoleukodystrophy in elderly males | Request PDF". Archived from the original on 2021-04-18. Retrieved 2021-02-05.

wiley.com (Global: 222^nd place; English: 297^th place)

onlinelibrary.wiley.com

Bezman, Lena; Moser, Ann B.; Raymond, Gerald V.; Rinaldo, Piero; Watkins, Paul A.; Smith, Kirby D.; Kass, Nancy E.; Moser, Hugo W. (2001). "Adrenoleukodystrophy: Incidence, new mutation rate, and results of extended family screening". Annals of Neurology. 49 (4): 512–517. doi:10.1002/ana.101. ISSN 1531-8249. PMID 11310629.

worldcat.org (Global: 5^th place; English: 5^th place)

search.worldcat.org

Huffnagel, Irene C.; Dijkgraaf, Marcel G. W.; Janssens, Georges E.; van Weeghel, Michel; van Geel, Björn M.; Poll-The, Bwee Tien; Kemp, Stephan; Engelen, Marc (2019-02-07). "Disease progression in women with X-linked adrenoleukodystrophy is slow". Orphanet Journal of Rare Diseases. 14 (1): 30. doi:10.1186/s13023-019-1008-6. ISSN 1750-1172. PMC 6367840. PMID 30732635.
Bezman, Lena; Moser, Ann B.; Raymond, Gerald V.; Rinaldo, Piero; Watkins, Paul A.; Smith, Kirby D.; Kass, Nancy E.; Moser, Hugo W. (2001). "Adrenoleukodystrophy: Incidence, new mutation rate, and results of extended family screening". Annals of Neurology. 49 (4): 512–517. doi:10.1002/ana.101. ISSN 1531-8249. PMID 11310629.
Raymond GV, Moser AB, Fatemi A (6 April 2023) [Originally published 26 March 1999]. "X-Linked Adrenoleukodystrophy". In Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Stephens K, Amemiya A (eds.). GeneReviews. Seattle: University of Washington, Seattle. ISSN 2372-0697. PMID 20301491. National Library of Medicine Bookshelf ID NBK1315.
Bouquet, Floriane; Dehais, Caroline; Sanson, Marc; Lubetzki, Catherine; Louapre, Céline (December 2015). "Dramatic worsening of adult-onset X-linked adrenoleukodystrophy after head trauma". Neurology. 85 (22): 1991–1993. doi:10.1212/WNL.0000000000002173. ISSN 0028-3878. PMID 26537054.
Budhram, Adrian; Pandey, Sachin K. (September 2017). "Activation of Cerebral X-linked Adrenoleukodystrophy After Head Trauma". Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 44 (5): 597–598. doi:10.1017/cjn.2017.52. ISSN 0317-1671. PMID 28534457.
Morató, Laia; Galino, Jorge; Ruiz, Montserrat; Calingasan, Noel Ylagan; Starkov, Anatoly A.; Dumont, Magali; Naudí, Alba; Martínez, Juan José; Aubourg, Patrick; Portero-Otín, Manuel; Pamplona, Reinald; Galea, Elena; Beal, M. Flint; Ferrer, Isidre; Fourcade, Stéphane (August 2013). "Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy". Brain. 136 (8): 2432–2443. doi:10.1093/brain/awt143. ISSN 1460-2156. PMC 4550111. PMID 23794606.
Rodríguez-Pascau, Laura; Vilalta, Anna; Cerrada, Marc; Traver, Estefania; Forss-Petter, Sonja; Weinhofer, Isabelle; Bauer, Jan; Kemp, Stephan; Pina, Guillem; Pascual, Sílvia; Meya, Uwe; Musolino, Patricia L.; Berger, Johannes; Martinell, Marc; Pizcueta, Pilar (2021-06-02). "The brain penetrant PPARγ agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy". Science Translational Medicine. 13 (596) eabc0555. doi:10.1126/scitranslmed.abc0555. ISSN 1946-6234. PMID 34078742.
Köhler, Wolfgang; Engelen, Marc; Eichler, Florian; Lachmann, Robin; Fatemi, Ali; Sampson, Jacinda; Salsano, Ettore; Gamez, Josep; Molnar, Maria Judit; Pascual, Sílvia; Rovira, Maria; Vilà, Anna; Pina, Guillem; Martín-Ugarte, Itziar; Mantilla, Adriana (2023-02-01). "Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2–3 trial". The Lancet Neurology. 22 (2): 127–136. doi:10.1016/S1474-4422(22)00495-1. ISSN 1474-4422. PMC 11847323. PMID 36681445.

Adrenoleukodystrophy (English Wikipedia)

ajnr.org (Global: low place; English: low place)

businesswire.com (Global: 615th place; English: 407th place)

cambridge.org (Global: 305th place; English: 264th place)

doi.org (Global: 2nd place; English: 2nd place)

elsevier.com (Global: 610th place; English: 704th place)

linkinghub.elsevier.com

europa.eu (Global: 68th place; English: 117th place)

ema.europa.eu

fiercepharma.com (Global: low place; English: 8,921st place)

harvard.edu (Global: 18th place; English: 17th place)

ui.adsabs.harvard.edu

neurology.org (Global: 9,919th place; English: low place)

nih.gov (Global: 4th place; English: 4th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

omim.org (Global: 4,380th place; English: 4,305th place)

researchgate.net (Global: 120th place; English: 125th place)

science.org (Global: 1,160th place; English: 737th place)

semanticscholar.org (Global: 11th place; English: 8th place)

api.semanticscholar.org

sps.nhs.uk (Global: low place; English: low place)

uzh.ch (Global: 3,633rd place; English: 3,091st place)

zora.uzh.ch

web.archive.org (Global: 1st place; English: 1st place)

wiley.com (Global: 222nd place; English: 297th place)

onlinelibrary.wiley.com

worldcat.org (Global: 5th place; English: 5th place)

search.worldcat.org

businesswire.com (Global: 615^th place; English: 407^th place)

cambridge.org (Global: 305^th place; English: 264^th place)

doi.org (Global: 2^nd place; English: 2^nd place)

elsevier.com (Global: 610^th place; English: 704^th place)

europa.eu (Global: 68^th place; English: 117^th place)

fiercepharma.com (Global: low place; English: 8,921^st place)

harvard.edu (Global: 18^th place; English: 17^th place)

neurology.org (Global: 9,919^th place; English: low place)

nih.gov (Global: 4^th place; English: 4^th place)

omim.org (Global: 4,380^th place; English: 4,305^th place)

researchgate.net (Global: 120^th place; English: 125^th place)

science.org (Global: 1,160^th place; English: 737^th place)

semanticscholar.org (Global: 11^th place; English: 8^th place)

uzh.ch (Global: 3,633^rd place; English: 3,091^st place)

web.archive.org (Global: 1^st place; English: 1^st place)

wiley.com (Global: 222^nd place; English: 297^th place)

worldcat.org (Global: 5^th place; English: 5^th place)